A 65-year-elderly person with hypertension, immune system hypothyroidism, and known Covid-19 presentation introduced to the crisis division with a 4-day history of weakness, fever, dry hack and stomach uneasiness. She was afebrile and had a respiratory pace of 28 breaths for every moment and an oxygen immersion of 89% while she was breathing encompassing air; breath sounds were decreased respectively with bibasilar rales. The stomach assessment was ordinary. Research center tests demonstrated an ordinary white-cell check, hemoglobin level (14.2g per deciliter) and platelet tally (183,000 for each cubic millimeter). The C-receptive protein level was raised at 55 mg for each liter, and liver-work tests indicated cholestasis. An oropharyngeal swab for Covid-19 testing was certain. Chest processed tomography (CT) demonstrated ground-glass opacities in the lower zones. The patient was conceded and started to get treatment with intravenous amoxicillin clavulanic corrosive, low-atomic weight heparin, and oxygen.

References

1. Neunert C., et al. “American Society of Hematology 2019 guidelines for immune thrombocytopenia”. Blood Advances 23 (2019): 3829-3866.
2. Provan D., et al. “Updated international consensus report on the investigation and management of primary immune thrombocytopenia”. Blood Advances 22 (2019): 3780-3817.
3. Lippi G., et al. “Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis”. Clinica Chimica Acta 506 (2020): 145-148.

Citation

Citation: Indranil Chatterjee and Rakhi Bakuli. “A COVID-19 Patient with Immune Thrombocytopenic Purpura". Acta Scientific Microbiology 3.7 (2020): 56-57.

Copyright

Copyright: © 2020 Indranil Chatterjee and Rakhi Bakuli. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.